Literature DB >> 6193192

Evidence that anti-idiotype induced immunity to experimental African trypanosomiasis is genetically restricted and requires recognition of combining site-related idiotopes.

D L Sacks, A Sher.   

Abstract

The ability of anti-idiotypic (anti-Id) antibodies to immunize mice against African trypanosomiasis independent of antigen has been confirmed. Of three allogeneic anti-Id antibodies raised against three protective monoclonal antibodies, each with specificity for the variant surface antigen of a clone of Trypanosoma rhodesiense, only one (anti-7H11 Id) was effective in immunizing BALB/c mice against homologous challenge. The immunity was associated with the more rapid and enhanced expression of the corresponding Id after infection. The immunity was restricted to mice bearing genes linked to Igh-Ca, which appeared to control expression of this Id both in response to infection and anti-Id treatment. Another Id, 11D5, appeared to be under similar genetic control. Anti-11D5 Id, however, was ineffective in immunizing mice against infection despite inducing high levels of Id bearing molecules before challenge. The immunizing potential of the respective anti-Id antibodies appeared to be related to the relative concentrations of antibodies reactive with idiotopes near to or within the antigen-combining site, which, in turn, determined the relative proportion of Id-bearing clones activated that had antigen binding activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193192

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Genetic engineering of plants for virus resistance.

Authors:  F Gadani; L M Mansky; R Medici; W A Miller; J H Hill
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Monoclonal antibodies: a potentially powerful tool in the diagnosis and treatment of infectious diseases.

Authors:  G Spira; R R Pollock; A Bargellesi; M D Scharff
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

3.  Monoclonal 'internal image' anti-idiotypic antibodies of hepatitis B surface antigen.

Authors:  Y M Thanavala; A Bond; R Tedder; F C Hay; I M Roitt
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

Review 4.  Idiotypic vaccines and infectious diseases.

Authors:  J R Hiernaux
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

5.  IgVH determined genetic restriction of a non-internal image monoclonal anti-idiotypic vaccine against Semliki Forest virus.

Authors:  T A Oosterlaken; M Harmsen; G L Ekstijn; C A Kraaijeveld; H Snippe
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

6.  Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies.

Authors:  L Polonelli; N Séguy; S Conti; M Gerloni; D Bertolotti; C Cantelli; W Magliani; J C Cailliez
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

7.  A conserved coronavirus epitope, critical in virus neutralization, mimicked by internal-image monoclonal anti-idiotypic antibodies.

Authors:  C Suñé; C Smerdou; I M Antón; P Abril; J Plana; L Enjuanes
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

8.  Antiidiotypic antibody vaccine in murine Schistosomiasis mansoni comprising the internal image of antigen.

Authors:  T F Kresina; G R Olds
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

9.  Enhancement of antibody production to hepatitis B surface antigen by anti-idiotypic antibody.

Authors:  S Kakumu; K Murase; A Tsubouchi; K Yoshioka; N Sakamoto
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

10.  Yeast killer toxin-like anti-idiotypic antibodies.

Authors:  L Polonelli; G Morace
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.